INVESTIS N/ CH0325094297 /
2024-03-28 5:30:28 PM | Chg. +0.60 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
97.20CHF | +0.62% | 804 Turnover: 78,019.40 |
97.00Bid Size: 50 | 97.60Ask Size: 77 | 1.24 bill.CHF | 2.57% | - |
Newsfile Corp
03-07
La Première Nation de Fort McKay et Suncor Énergie collaboreront dans le cadre d'une occasion de mis...
GlobeNewswire
01-09
Inside information: Faron Announces First HMA-failed MDS Patient Dosed with Bexmarilimab as part of ...
GlobeNewswire
2023-12-11
Inside information: Faron Presents Phase 1 Data from BEXMAB in Myeloid Malignancies Trial at the 65t...
GlobeNewswire
2023-12-04
Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position...
GlobeNewswire
2023-11-06
Insider information: Faron Initiates Phase 2 Part of BEXMAB Study of Bexmarilimab in HMA-failed MDS
GlobeNewswire
2021-10-19
Oxford Biomedica Announces that Boehringer Ingelheim has Exercised Option Relating to a Novel Gene T...
GlobeNewswire
2021-09-30
AIM ImmunoTech Announces Clinical Trial Agreement for a Phase 2a Human Challenge Trial of Ampligen a...
euro adhoc
2021-08-12
EANS-Tip Announcement: Österreichische Post AG / Half-year financial report according to art. 125 pa...
GlobeNewswire
2020-10-08
Invitation OXURION R&D Investor Day – Virtual - 15 October 2020 at 5.30pm CET/ 11.30am ET
GlobeNewswire
2018-09-13
Scapa Healthcare Enters Agreement to Acquire Advanced Wound Dressing Facility in the UK
GlobeNewswire
2018-05-29
Allergy Therapeutics plc - Positive new data with house-dust mite immunotherapy
GlobeNewswire
2016-07-29
Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...
GlobeNewswire
2013-05-23
TGS Announces New Multi-client Surveys and Partnerships at its 2013 Capital Markets Day